PubMed for id: 2746

Year	Number of Results
1979	1
1982	1
1985	1
1987	2
1988	3
1989	1
1992	1
1993	4
1994	1
1998	1
1999	1
2000	2
2001	5
2002	9
2003	4
2004	8
2005	6
2006	4
2008	6
2009	8
2010	12
2011	9
2012	6
2013	5
2014	18
2015	33
2016	19
2017	12
2018	17
2019	15
2020	19
2021	9
2022	17
2023	11
2024	4

1

Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma.

Liu S. Liu S. Eur J Med Res. 2024 Jan 20;29(1):70. doi: 10.1186/s40001-024-01649-2. Eur J Med Res. 2024. PMID: 38245763 Free PMC article.

2

Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome.

Boodhansingh KE, Rosenfeld E, Lord K, Adzick NS, Bhatti T, Ganguly A, De Leon DD, Stanley CA. Boodhansingh KE, et al. Horm Res Paediatr. 2022;95(5):492-498. doi: 10.1159/000526203. Epub 2022 Aug 11. Horm Res Paediatr. 2022. PMID: 35952631 Free PMC article.

3

Mapping the Intramolecular Communications among Different Glutamate Dehydrogenase States Using Molecular Dynamics.

Basith S, Manavalan B, Shin TH, Lee G. Basith S, et al. Biomolecules. 2021 May 27;11(6):798. doi: 10.3390/biom11060798. Biomolecules. 2021. PMID: 34072154 Free PMC article.

4

Hyperinsulinism hyperammonaemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution.

Brandt A, Agarwal N, Giri D, Yung Z, Didi M, Senniappan S. Brandt A, et al. J Pediatr Endocrinol Metab. 2020 May 26;33(5):675-679. doi: 10.1515/jpem-2019-0416. J Pediatr Endocrinol Metab. 2020. PMID: 32229669

5

Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase.

Luczkowska K, Stekelenburg C, Sloan-Béna F, Ranza E, Gastaldi G, Schwitzgebel V, Maechler P. Luczkowska K, et al. Hum Genomics. 2020 Mar 6;14(1):9. doi: 10.1186/s40246-020-00262-8. Hum Genomics. 2020. PMID: 32143698 Free PMC article.

6

Glutamate dehydrogenase inhibits tumor growth in gastric cancer through the Notch signaling pathway.

Wu YJ, Hu ZL, Hu SD, Li YX, Xing XW, Yang Y, Du XH. Wu YJ, et al. Cancer Biomark. 2019;26(3):303-312. doi: 10.3233/CBM-190022. Cancer Biomark. 2019. PMID: 31322543

7

Glutamate dehydrogenase (GLUD1) expression in breast cancer.

Craze ML, El-Ansari R, Aleskandarany MA, Cheng KW, Alfarsi L, Masisi B, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR. Craze ML, et al. Breast Cancer Res Treat. 2019 Feb;174(1):79-91. doi: 10.1007/s10549-018-5060-z. Epub 2018 Nov 23. Breast Cancer Res Treat. 2019. PMID: 30470977

8

Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients.

Su C, Liang XJ, Li WJ, Wu D, Liu M, Cao BY, Chen JJ, Qin M, Meng X, Gong CX. Su C, et al. J Diabetes Res. 2018 Sep 16;2018:2802540. doi: 10.1155/2018/2802540. eCollection 2018. J Diabetes Res. 2018. PMID: 30306091 Free PMC article.

9

The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.

Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha Y, Li D, Alesi GN, Kang Y, Zhou L, Yu WM, Magliocca KR, Khuri FR, Qu CK, Metallo C, Owonikoko TK, Kang S. Jin L, et al. Mol Cell. 2018 Jan 4;69(1):87-99.e7. doi: 10.1016/j.molcel.2017.11.025. Epub 2017 Dec 14. Mol Cell. 2018. PMID: 29249655 Free PMC article.

10

[Effect of GLUD1 on proliferation, osteogenic differentiation and mineralization of human dental pulp stem cells].

Lu X, Liu SF, Zhao SL. Lu X, et al. Shanghai Kou Qiang Yi Xue. 2017 Aug;26(4):358-362. Shanghai Kou Qiang Yi Xue. 2017. PMID: 29199326 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

248 results

Results by year